Cargando…

SIRPα Suppresses Response to Therapeutic Antibodies by Nurse Like Cells From Chronic Lymphocytic Leukemia Patients

Targeted antibody therapies improve outcomes for chronic lymphocytic leukemia (CLL) patients. However, resistance often develops. We have previously shown that resistance to therapeutic antibodies, by monocyte derived macrophages (referred to as nurse like cells, NLCs), from CLL patients is characte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yu-Chen Enya, Burgess, Melinda, Mapp, Sally, Mollee, Peter, Gill, Devinder, Blumenthal, Antje, Saunders, Nicholas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859087/ https://www.ncbi.nlm.nih.gov/pubmed/33552071 http://dx.doi.org/10.3389/fimmu.2020.610523

Ejemplares similares

Targeting SIRPα in cancer
por: Ho, Jenny M., et al.
Publicado: (2013)

Anticancer efficacy of monotherapy with antibodies to SIRPα/SIRPβ1 mediated by induction of antitumorigenic macrophages
por: Sakamoto, Mariko, et al.
Publicado: (2021)

Transcriptomic analysis of monocytes and macrophages derived from CLL patients which display differing abilities to respond to therapeutic antibody immune complexes
por: Burgess, M., et al.
Publicado: (2015)

SIRPα-antibody fusion proteins stimulate phagocytosis and promote elimination of acute myeloid leukemia cells
por: Ponce, Laia Pascual, et al.
Publicado: (2017)

SIRPαFc treatment targets human acute myeloid leukemia stem cells
por: Galkin, Oleksandr, et al.
Publicado: (2020)

OX130 Monoclonal Antibody Recognizes Human SIRPβ1 but Cross-Reacts on SIRPα from One Allele
por: Hatherley, Deborah, et al.
Publicado: (2016)

Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint
por: Voets, Erik, et al.
Publicado: (2019)

Potential New Cancer Immunotherapy: Anti-CD47-SIRPα Antibodies
por: Lu, Quansheng, et al.
Publicado: (2020)

Membrane-Mediated Cooperative Interactions of CD47 and SIRPα
por: Li, Long, et al.
Publicado: (2023)

Cancer Therapy Targeting CD47/SIRPα
por: Dizman, Nazli, et al.
Publicado: (2021)

BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells
por: van Helden, Mary J, et al.
Publicado: (2023)

Improving macrophage responses to therapeutic antibodies by molecular engineering of SIRPα variants
por: Weiskopf, Kipp, et al.
Publicado: (2013)

Anti‐human SIRPα antibody is a new tool for cancer immunotherapy
por: Murata, Yoji, et al.
Publicado: (2018)

Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts
por: Theocharides, Alexandre P.A., et al.
Publicado: (2012)

Engagement of SIRPα Inhibits Growth and Induces Programmed Cell Death in Acute Myeloid Leukemia Cells
por: Irandoust, Mahban, et al.
Publicado: (2013)

Nicotine Suppresses Phagocytic Ability of Macrophages by Regulating the miR-296-3p–SIRPα Axis
por: Liu, Zhen, et al.
Publicado: (2023)

Synapse Maturation by Activity-Dependent Ectodomain Shedding of SIRPα
por: Toth, Anna B., et al.
Publicado: (2013)

The SIRPα–CD47 immune checkpoint in NK cells
por: Deuse, Tobias, et al.
Publicado: (2021)

CD47–SIRPα-targeted therapeutics: status and prospects
por: Maute, R., et al.
Publicado: (2022)

Leishmania Infection-Induced Proteolytic Processing of SIRPα in Macrophages
por: Hirai, Hana, et al.
Publicado: (2023)

Preclinical characterization of the novel anti-SIRPα antibody BR105 that targets the myeloid immune checkpoint
por: Wu, Zhen-Hua, et al.
Publicado: (2022)

Loss of microglial SIRPα promotes synaptic pruning in preclinical models of neurodegeneration
por: Ding, Xin, et al.
Publicado: (2021)

SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells
por: Nuvolone, Mario, et al.
Publicado: (2013)

The Immunotherapeutic Effect of SIRPα-Silenced DCs against Cervical Cancer
por: Li, Xiaojie, et al.
Publicado: (2020)

Insights into CD47/SIRPα axis-targeting tumor immunotherapy
por: Zhang, Xuyao, et al.
Publicado: (2018)

CD47/SIRPα axis: bridging innate and adaptive immunity
por: van Duijn, Anneloes, et al.
Publicado: (2022)

Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis
por: Okamoto, Takeshi, et al.
Publicado: (2023)

SIRPα blockade improves the antitumor immunity of radiotherapy in colorectal cancer
por: Ji, Kai, et al.
Publicado: (2023)

Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors
por: Miller, Thomas W., et al.
Publicado: (2019)

Soluble SIRP-Alpha Promotes Murine Acute Lung Injury Through Suppressing Macrophage Phagocytosis
por: Shen, Qinjun, et al.
Publicado: (2022)

Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
por: Zhang, Wenting, et al.
Publicado: (2020)

MICROGLIA MAY INSTRUCT SYNAPTIC FATE VIA SIRPα IN MOUSE RETINA
por: Jiang, Danye, et al.
Publicado: (2019)

CD47/SIRPα pathway mediates cancer immune escape and immunotherapy
por: Jia, Xiao, et al.
Publicado: (2021)

Concerted BAG3 and SIRPα blockade impairs pancreatic tumor growth
por: De Marco, Margot, et al.
Publicado: (2022)

SIRPα on Mouse B1 Cells Restricts Lymphoid Tissue Migration and Natural Antibody Production
por: Franke, Katka, et al.
Publicado: (2020)

Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils
por: Behrens, Leonie M., et al.
Publicado: (2022)

Binding Mechanism of CD47 with SIRPα Variants and Its Antibody: Elucidated by Molecular Dynamics Simulations
por: Huang, Kaisheng, et al.
Publicado: (2023)

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy
por: Wang, Hongfei, et al.
Publicado: (2020)

Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis()()
por: Vaeteewoottacharn, Kulthida, et al.
Publicado: (2018)

Delivery of CD47 blocker SIRPα-Fc by CAR-T cells enhances antitumor efficacy
por: Chen, Huanpeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_19a92sn5rh3r93jj801cgi8enj